/BTCY
BTCY Stock - Biotricity, Inc.
Healthcare|Medical - DevicesOTC
$0.39-2.50%
$0.01 (-2.50%) • Dec 19
61
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.12
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.66
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+925.6%upside
Target: $4.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BTCY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.39 – $0.39
TARGET (TP)$4.00
STOP LOSS$0.36
RISK/REWARD1:120.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.34
52W High$0.83
52W Low$0.24
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $13.79M | $12.06M | $9.64M | $7.65M | $3.38M |
| Gross Profit | $10.56M | $8.36M | $5.44M | $4.57M | $1.27M |
| Gross Margin | 76.6% | 69.3% | 56.5% | 59.7% | 37.6% |
| Operating Income | $-2,448,966 | $-8,828,269 | $-15,409,711 | $-16,736,802 | $-13,199,997 |
| Net Income | $-8,421,179 | $-14,094,283 | $-18,658,143 | $-29,130,477 | $-15,491,176 |
| Net Margin | -61.1% | -116.8% | -193.6% | -380.8% | -457.7% |
| EPS | $-0.55 | $-1.66 | $-2.26 | $-3.99 | $-2.63 |
Company Overview
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
0%
Hold / Neutral
1
100%
Sell / Underperform
0%
Analyst Consensus🔴 Bearish
0 Bullish1 Neutral/Bearish
Price Targets
No price targets available
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 20th 2023 | H.C. Wainwright | Downgrade | Neutral | - |
Earnings History & Surprises
BTCYBeat Rate
50%
Last 16 quarters
Avg Surprise
+13.8%
EPS vs Estimate
Beats / Misses
8/5
3 met exactly
Latest EPS
$-0.03
Q4 2025
EPS Surprise History
Q1 24
+17.1%
$-0.34vs$-0.41
Q2 24
-30.6%
$-0.47vs$-0.36
Q3 24
No data
Q4 24
No data
Q1 25
+54.5%
$-0.05vs$-0.11
Q3 25
+40.0%
$-0.06vs$-0.10
Q3 25
+66.7%
$-0.03vs$-0.09
Q4 25
+62.5%
$-0.03vs$-0.08
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 18, 2026 | $-0.08 | — | — | — |
Q4 2025 | Nov 14, 2025 | $-0.08 | $-0.03 | +62.5% | ✓ BEAT |
Q3 2025 | Aug 14, 2025 | $-0.09 | $-0.03 | +66.7% | ✓ BEAT |
Q3 2025 | Jul 15, 2025 | $-0.10 | $-0.06 | +40.0% | ✓ BEAT |
Q1 2025 | Feb 19, 2025 | $-0.11 | $-0.05 | +54.5% | ✓ BEAT |
Q4 2024 | Nov 14, 2024 | — | $-0.07 | — | — |
Q3 2024 | Aug 19, 2024 | — | $-0.49 | — | — |
Q2 2024 | Jun 26, 2024 | $-0.36 | $-0.47 | -30.6% | ✗ MISS |
Q1 2024 | Feb 20, 2024 | $-0.41 | $-0.34 | +17.1% | ✓ BEAT |
Q4 2023 | Nov 14, 2023 | $-0.34 | $-0.44 | -29.4% | ✗ MISS |
Q3 2023 | Aug 14, 2023 | $-0.41 | $-0.07 | +82.9% | ✓ BEAT |
Q2 2023 | Jun 29, 2023 | $-0.54 | $-0.54 | 0.0% | = MET |
Q1 2023 | Feb 14, 2023 | $-0.54 | $-0.54 | 0.0% | = MET |
Q4 2022 | Nov 14, 2022 | $-0.48 | $-0.54 | -12.5% | ✗ MISS |
Q3 2022 | Aug 15, 2022 | $-0.78 | $-0.60 | +23.1% | ✓ BEAT |
Q3 2022 | Jul 14, 2022 | $-0.60 | $-0.72 | -20.0% | ✗ MISS |
Q1 2022 | Feb 14, 2022 | $-0.90 | $-0.90 | 0.0% | = MET |
Q4 2021 | Nov 4, 2021 | $-0.54 | $-0.78 | -44.4% | ✗ MISS |
Q3 2021 | Aug 16, 2021 | $-0.54 | $-0.48 | +11.1% | ✓ BEAT |
Q2 2021 | Jun 21, 2021 | — | $-0.90 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BTCY
What is BTCY's current stock price?
Biotricity, Inc. (BTCY) is currently trading at $0.39 per share. The stock has moved -2.50% today.
What is the analyst price target for BTCY?
The average analyst price target for BTCY is $4.00, based on 1 analyst.
What sector is Biotricity, Inc. in?
Biotricity, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is BTCY's market cap?
Biotricity, Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does BTCY pay dividends?
No, Biotricity, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALRTF
ALR Technologies Inc.
$0.02
Mkt Cap: $0.0B
ASAPF
Aurora Spine Corporation
$0.20
Mkt Cap: $0.0B
CLCS
Cell Source, Inc.
$0.50
Mkt Cap: $0.0B
CRVW
CareView Communications, Inc.
$0.02
Mkt Cap: $0.0B
GLABF
Gemina Laboratories Ltd.
$0.09
Mkt Cap: $0.0B
GTHP
Guided Therapeutics, Inc.
$0.35
Mkt Cap: $0.0B
IMMVF
Immunovia AB (publ)
$0.05
Mkt Cap: $0.0B
RYAHF
RYAH Group, Inc.
$0.01
Mkt Cap: $0.0B
UEEC
United Health Products, Inc.
$0.06
Mkt Cap: $0.0B
VPTDF
VentriPoint Diagnostics Ltd.
$0.09
Mkt Cap: $0.0B
Explore stocks similar to BTCY for comparison